Maximum resection and immunotherapy improve glioblastoma patient survival: a retrospective single-institution prognostic analysis

Glioblastoma (GBM) is a refractory disease with a poor prognosis and various methods, including maximum resection and immunotherapy, have been tested to improve outcomes. In this retrospective study we analyzed the prognostic factors of 277 newly diagnosed GBM patients over 11 years of consecutive c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Eiichi, Sugii, Narushi, Matsuda, Masahide, Kohzuki, Hidehiro, Tsurubuchi, Takao, Akutsu, Hiroyoshi, Takano, Shingo, Mizumoto, Masashi, Sakurai, Hideyuki, Matsumura, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287820/
https://www.ncbi.nlm.nih.gov/pubmed/34281518
http://dx.doi.org/10.1186/s12883-021-02318-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287820/
https://www.ncbi.nlm.nih.gov/pubmed/34281518
http://dx.doi.org/10.1186/s12883-021-02318-1

Ejemplares similares